The immuno side of melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
16 Jul 2012

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

The changing field of drug development

Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
The changing field of drug development ( Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly )
16 Jul 2012

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012

Perifosine disappoints in refractory mCRC

Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012

Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment

Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy
Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment ( Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy )
16 Jul 2012

Young Voices United against CRC

Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
Young Voices United against CRC ( Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia )
16 Jul 2012

Advances in radiotherapy for rectal cancer

Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer  ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012

Use of electronic data to raise the standard of cancer care

Brett Davis – Oracle Corporation, USA
Use of electronic data to raise the standard of cancer care  ( Brett Davis – Oracle Corporation, USA )
16 Jul 2012

Addressing Asia’s high cancer incidence

Dr Bin Teh - SingHealth Group, Singapore
Addressing Asia’s high cancer incidence  ( Dr Bin Teh - SingHealth Group, Singapore )
13 Jul 2012

The involvement of rare cancer patients in clinical research

Jan Geissler - Co-founder of CML Advocates Network
The involvement of rare cancer patients in clinical research ( Jan Geissler - Co-founder of CML Advocates Network )
12 Jul 2012

Importance of early detection and the ‘Beyond the Shock’ programme

Dr Douglas Feil – National Breast Cancer Foundation, USA
Importance of early detection and the ‘Beyond the Shock’ programme ( Dr Douglas Feil – National Breast Cancer Foundation, USA )
6 Jul 2012